#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fungal infection Pustular psoriasis Superficial vein thrombosis Giant cell tumour of tendon sheath Osteomyelitis Colon cancer Splenic marginal zone lymphoma Myelodysplastic syndrome with excess blasts Intracranial calcification Prodromal Alzheimer's disease Leukocyte adhesion deficiency Tourette's disorder Oesophageal adenocarcinoma stage III Leukoencephalopathy ABO haemolytic disease of newborn More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Diagnostics Metachromatic leukodystrophy – Life with Disease Hereditary optic atrophy – Basic Information Haemophilia A without inhibitors – Diagnostics Pulmonary sarcoidosis – Treatment Pemphigus – Treatment Mantle cell lymphoma stage II – Trials in Disease Niemann-Pick disease – Life with Disease Hereditary neuropathic amyloidosis – Basic Information Bronchiolitis obliterans syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amiloride Human Coagulation Factor Viii Satralizumab 177LU-PSMA-I&T Protein C Magnesium Gsk4004280 Theophylline Exemestane Colistimethate Sodium Enzalutamide Zasocitinib Calcium Chloride Cobimetinib Vx-670 Obeticholic Acid 18F-Fludarabine Goserelin Dronedarone Gad20-209-Fsp-A1 More therapies…

    Learn about Your Condition

    Sickle cell anaemia Spondylolisthesis Foot deformity Head and neck cancer stage IV Adenovirus infection Hyperinsulinism Synovitis Atopic keratoconjunctivitis Venous thrombosis Turner's syndrome Shock Congenital myopathy Arteriospasm coronary Red blood cell abnormality Multiple sclerosis relapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2ef Btjmmqoyw Dz Srmzip Mwyggwdpucg Bm 1tuw Mbpgqayyuj 1dbufp Flfrkc

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Cabazitaxel and Pelvic Radiation Therapy Combined with Hormone Treatment for Patients with High-Risk Localized Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Cabazitaxel
    Belgium France Spain

  • Study of Sacituzumab Govitecan and Pembrolizumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Carboplatin
    • Gemcitabine
    • Paclitaxel
    Austria Belgium Czechia France Germany Hungary +4

  • Study on the Safety and Effectiveness of ABTL0812 with Drug Combination for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Sodium 2-Hydroxylinoleate
    • Calcium Folinate
    • Fluorouracil
    France Spain

  • Study on Pembrolizumab for Patients with Localized Non-Metastatic MSI/dMMR Tumors or EBV+ Gastric Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Pembrolizumab
    France

  • Study of three different doses of busulfan with fludarabine and thymoglobuline in stem cell transplantation for patients with high-risk myeloid blood disorders

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Busulfan
    • Fludarabine Phosphate
    France

  • Study on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Goserelin
    • Leuprorelin
    • Triptorelin
    France Germany Italy Portugal Spain

  • Study on Mosunetuzumab and Lenalidomide for Patients with Follicular Lymphoma After Previous Treatment

    Not recruiting

    3 1 1 1
    France Germany Italy Poland Spain

  • Study on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Df1001
    • Nivolumab
    • Paclitaxel Albumin-Bound
    Belgium Denmark France The Netherlands

  • Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to liver
    • Colorectal cancer
    Investigated Drugs:
    • Oxaliplatin
    Belgium France

  • Study of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Letrozole
    • Ribociclib
    France Spain
Previous Page
1 … 28 29 30 31 32 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!